miR-486 is a myogenic microRNA, and its reduced skeletal muscle expression is observed
in muscular dystrophy. Transgenic overexpression of miR-486 using muscle creatine kinase …

Duchenne muscular dystrophy is a severe pediatric neuromuscular disorder caused by the
lack of dystrophin. Identification of biomarkers is needed to support and accelerate drug …

Simple Summary Oral cancer is a life-threatening disease and among the ten most common
cancer types. Specific protein biomarkers in the blood of these patients may allow early …

Despite promising therapeutic avenues, there is currently no effective treatment for
Duchenne muscular dystrophy (DMD), a lethal monogenic disorder caused by the loss of the …

Abstract Study Objectives Obstructive sleep apnea (OSA) is characterized by recurrent
partial to complete upper airway obstructions during sleep, leading to repetitive arousals …

Muscular dystrophies are a group of inherited disorders that primarily affect the muscle
tissues. Across the muscular dystrophies, symptoms commonly compromise the quality of …

Muscular dystrophies are a clinically and heterogeneous group of disorders that all share
clinical characteristics of progressive muscular weakness. Duchenne muscular dystrophy …

Abstract Study Objectives Kleine–Levin syndrome (KLS) is characterized by relapsing–
remitting episodes of hypersomnia, cognitive impairment, and behavioral disturbances. We …

Although the genetic basis of Duchenne muscular dystrophy has been known for almost
thirty years, the cellular and molecular mechanisms characterizing the disease are not …

Muscular dystrophies are characterized by a progressive loss of muscle tissue and/or
muscle function. While metabolic alterations have been described in patients'‐derived …